SOLASTA Bio, a Glasgow-based agri-biotech startup, has secured $14 million in Series A funding to accelerate the development of its innovative, nature-inspired bioinsecticides. The funding round, led by Forbion, included significant investments from FMC Ventures and Corteva Inc.
SOLASTA Bio's technology platform is based on natural principles, creating insect control agents that are both effective and environmentally friendly.
SOLASTA Bio's biopeptides offer a sustainable alternative to traditional synthetic insecticides, addressing the growing concerns of insect resistance, regulatory pressures, and consumer demand for chemical-free solutions.
SOLASTA Bio is positioned as a leader in sustainable crop protection, providing a solution for the growing need to protect pollinators and wildlife while increasing agricultural productivity.
SOLASTA Bio's vision is to transform the agriculture industry by providing growers with sustainable and effective pest control solutions.
Ask anything...